AI tools are now embedded into clinical scheduling, drug dispensing, patient communications and diagnostic decision-making across the industry, according to an analysis authored by Alaap Shah, a member of the firm and co-chair of Epstein Becker Green’s AI Cross-Practice Working Group.
Shah’s analysis, published in TechReg Chronicle, said the shift carries direct implications beyond healthcare. Fin…
PYMNTS | Healthcare AI Has Left the Lab. Now Comes the Hard Part.
